Increase water intake between meals rather than during them
A Mayo Clinic summary of recent findings reported that the pattern may be explained by more frequent medical surveillance in people who start these medications
Management of acute kidney disease in type 2 diabetes: the potential role of GLP-1 RAs and SGLT2-Is
GLP-1 and Swollen Lymph Nodes: Causes and When to Seek Help Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide, dulaglutide, and liraglutide are increasingly prescribed in the UK for type 2 diabetes and weight management
This hormone helps: Regulate blood sugar levels Slow stomach emptying Promote a feeling of fullness For weight loss, GLP-1 medicationsmost notably Semaglutidecan significantly reduce body weight by decreasing appetite and improving how the body processes sugars
While sommarutide is undoubtedly an exciting potential treatment option, there is still a lack of clear clinical data on the mechanism of action of GLP-1 agonists in NASH, such as whether GLP-1 agonists have a direct, independent role in improving NASH, or simply by improving body weight, insulin resistance, and so on